Redcare Pharmacy N.V.
SAEYYOTCHealthcare● Active
$5.50
+$0.00(+0.00%)
Market Cap$1.1B
P/E Ratio—
52W High$12.6
52W Low$3.59
Redcare Pharmacy N.V. (SAEYY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SAEYY · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.82B | $2.37B | $1.80B | $1.20B | $1.06B |
| Cost of Revenue | $2.25B | $1.82B | $1.36B | $0.87B | $0.79B |
| Gross Profit | $0.57B | $0.55B | $0.44B | $0.33B | $0.27B |
| Gross Margin %(computed) | 20.19% | 23.02% | 24.48% | 27.55% | 25.14% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.05B | $0.08B | $0.03B | $0.03B | $0.02B |
| Total Operating Expenses | $0.59B | $0.58B | $0.46B | $0.40B | $0.31B |
| Operating Income | ($0.02B) | ($0.04B) | ($0.02B) | ($0.07B) | ($0.07B) |
| Operating Margin %(computed) | -0.81% | -1.64% | -0.96% | -5.74% | -6.20% |
| Interest Income | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.02B | $0.01B | $0.02B | $0.01B | $0.01B |
| Income Before Tax | ($0.05B) | ($0.05B) | ($0.01B) | ($0.08B) | ($0.08B) |
| Income Tax Expense | ($0.01B) | ($0.00B) | ($0.00B) | ($0.01B) | ($0.00B) |
| Net Income | ($0.04B) | ($0.05B) | ($0.01B) | ($0.08B) | ($0.07B) |
| Net Margin %(computed) | -1.28% | -1.92% | -0.67% | -6.45% | -7.00% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.18 | $-0.23 | $-0.06 | $-0.43 | $-0.41 |
| Wtd Avg Shares | 0.20B | 0.20B | 0.19B | 0.18B | 0.18B |
| EBITDA | $0.04B | ($0.01B) | $0.05B | ($0.03B) | ($0.04B) |
| EBITDA Margin %(computed) | 1.55% | -0.54% | 2.83% | -2.54% | -3.53% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · B
Explore more Redcare Pharmacy N.V. data
About Redcare Pharmacy N.V. (SAEYY) Income Statement
Redcare Pharmacy N.V. (SAEYY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SAEYY reported revenue of $2.82B, gross profit of $0.57B (gross margin 20.19%), and net income of ($0.04B) — a net profit margin of -1.28%.
Frequently asked questions
SAEYY · 4 questionsRedcare Pharmacy N.V. (SAEYY) reported revenue of $2.82B for 2025, up 19.2% year-over-year.
SAEYY revenueSAEYY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09